Antiretroviral Drug Interaction Study in Volunteers With HIV

NCT01479361 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

HIV
PCP
Toxoplasmosis

Interventions

DRUG: Atovaquone 750 mg twice daily
DRUG: Atovaquone 1500 mg twice daily

Sponsor

National Institutes of Health Clinical Center (CC)